Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Birkenstock Holding PLC stock logo
BIRK
Birkenstock
$34.92
-1.9%
$33.46
$29.93
▼
$50.73
$6.21B1.262.37 million shs1.17 million shs
Equinox Gold Corp. stock logo
EQX
Equinox Gold
$9.86
+0.3%
$11.21
$8.48
▼
$18.96
$11.52B1.3311.91 million shs8.88 million shs
Immunocore Holdings PLC Sponsored ADR stock logo
IMCR
Immunocore
$27.81
-3.7%
$30.92
$27.31
▼
$40.71
$1.43B0.82461,848 shs419,034 shs
10 Stocks Powering The Next AI Boom  Cover

The AI boom is creating opportunities across semiconductors, cloud computing, enterprise software, infrastructure, cybersecurity, and automation.

Inside this report, you’ll find 10 companies positioned to benefit as artificial intelligence moves from hype to real-world deployment and becomes a core growth driver for corporate America.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Birkenstock Holding PLC stock logo
BIRK
Birkenstock
-2.34%-8.51%+4.69%-4.88%-11.73%
Equinox Gold Corp. stock logo
EQX
Equinox Gold
-4.66%-18.69%-11.84%-14.15%-22.90%
Immunocore Holdings PLC Sponsored ADR stock logo
IMCR
Immunocore
-3.54%-8.98%-1.77%-19.82%-19.67%
CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Birkenstock Holding PLC stock logo
BIRK
Birkenstock
$34.92
-1.9%
$33.46
$29.93
▼
$50.73
$6.21B1.262.37 million shs1.17 million shs
Equinox Gold Corp. stock logo
EQX
Equinox Gold
$9.86
+0.3%
$11.21
$8.48
▼
$18.96
$11.52B1.3311.91 million shs8.88 million shs
Immunocore Holdings PLC Sponsored ADR stock logo
IMCR
Immunocore
$27.81
-3.7%
$30.92
$27.31
▼
$40.71
$1.43B0.82461,848 shs419,034 shs
10 Stocks Powering The Next AI Boom  Cover

The AI boom is creating opportunities across semiconductors, cloud computing, enterprise software, infrastructure, cybersecurity, and automation.

Inside this report, you’ll find 10 companies positioned to benefit as artificial intelligence moves from hype to real-world deployment and becomes a core growth driver for corporate America.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Birkenstock Holding PLC stock logo
BIRK
Birkenstock
-2.34%-8.51%+4.69%-4.88%-11.73%
Equinox Gold Corp. stock logo
EQX
Equinox Gold
-4.66%-18.69%-11.84%-14.15%-22.90%
Immunocore Holdings PLC Sponsored ADR stock logo
IMCR
Immunocore
-3.54%-8.98%-1.77%-19.82%-19.67%
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
Birkenstock Holding PLC stock logo
BIRK
Birkenstock
2.63
Moderate Buy$51.9148.66% Upside
Equinox Gold Corp. stock logo
EQX
Equinox Gold
2.88
Moderate Buy$14.0041.99% Upside
Immunocore Holdings PLC Sponsored ADR stock logo
IMCR
Immunocore
2.50
Moderate Buy$52.8690.07% Upside

Current Analyst Ratings Breakdown

Latest EQX, BIRK, and IMCR Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
11/16/2026
Immunocore Holdings PLC Sponsored ADR stock logo
IMCR
Immunocore
Reiterated RatingBuy
11/13/2026
Immunocore Holdings PLC Sponsored ADR stock logo
IMCR
Immunocore
Lower Price TargetEqual Weight$43.00 ➝ $42.00
11/10/2026
Immunocore Holdings PLC Sponsored ADR stock logo
IMCR
Immunocore
Lower Price TargetBuy$100.00 ➝ $80.00
11/9/2026
Immunocore Holdings PLC Sponsored ADR stock logo
IMCR
Immunocore
DowngradeHold ➝ Strong Sell
10/26/2026
Immunocore Holdings PLC Sponsored ADR stock logo
IMCR
Immunocore
Reiterated RatingBuy$100.00
10/21/2026
Equinox Gold Corp. stock logo
EQX
Equinox Gold
DowngradeHold ➝ Strong Sell
10/16/2026
Equinox Gold Corp. stock logo
EQX
Equinox Gold
Reiterated RatingOutperform
10/16/2026
Birkenstock Holding PLC stock logo
BIRK
Birkenstock
Lower Price TargetOutperform$52.00 ➝ $42.00
10/16/2026
Birkenstock Holding PLC stock logo
BIRK
Birkenstock
DowngradeHold ➝ Strong Sell
10/15/2026
Immunocore Holdings PLC Sponsored ADR stock logo
IMCR
Immunocore
Reiterated RatingSell (E+)
9/22/2026
Birkenstock Holding PLC stock logo
BIRK
Birkenstock
DowngradeHold (C) ➝ Hold (C-)
(Data available from 11/17/2023 forward. View 10+ years of historical ratings with our analyst ratings screener.)
CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
Birkenstock Holding PLC stock logo
BIRK
Birkenstock
$2.32B2.68$2.65 per share13.20$16.04 per share2.18
Equinox Gold Corp. stock logo
EQX
Equinox Gold
$1.82B6.34$0.66 per share14.84$8.53 per share1.16
Immunocore Holdings PLC Sponsored ADR stock logo
IMCR
Immunocore
$400.02M3.58N/AN/A$8.15 per share3.41
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
Birkenstock Holding PLC stock logo
BIRK
Birkenstock
$385.46M$2.1316.3613.131.1814.82%13.36%7.21%12/10/2026 (Estimated)
Equinox Gold Corp. stock logo
EQX
Equinox Gold
$221.47M$0.5410.387.83N/A23.83%9.95%6.18%N/A
Immunocore Holdings PLC Sponsored ADR stock logo
IMCR
Immunocore
-$35.51M-$0.65N/AN/AN/A-7.48%-7.96%-2.93%N/A

Latest EQX, BIRK, and IMCR Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
12/10/2026Q4 2026
Birkenstock Holding PLC stock logo
BIRK
Birkenstock
$0.5280N/AN/AN/A$689.85 millionN/A
11/9/2026Q3 2026
Equinox Gold Corp. stock logo
EQX
Equinox Gold
$0.1732$0.19+$0.0168$0.06$987.04 million$1.05 billion
11/6/2026Q3 2026
Immunocore Holdings PLC Sponsored ADR stock logo
IMCR
Immunocore
-$0.1749-$0.28-$0.1051-$0.28$152.09 million$102.22 million
CompanyAnnual PayoutDividend Yield5-Year Annualized Dividend GrowthPayout RatioYears of Consecutive Growth
Birkenstock Holding PLC stock logo
BIRK
Birkenstock
N/AN/AN/AN/AN/A
Equinox Gold Corp. stock logo
EQX
Equinox Gold
$0.090.92%N/A16.67%N/A
Immunocore Holdings PLC Sponsored ADR stock logo
IMCR
Immunocore
N/AN/AN/AN/AN/A

Latest EQX, BIRK, and IMCR Dividends

AnnouncementCompanyPeriodAmountYieldEx-Dividend DateRecord DatePayable Date
11/9/2026
Equinox Gold Corp. stock logo
EQX
Equinox Gold
quarterly$0.02250.74%11/25/202611/25/202612/10/2026
(Data available from 1/1/2013 forward)
CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
Birkenstock Holding PLC stock logo
BIRK
Birkenstock
0.67
3.78
2.09
Equinox Gold Corp. stock logo
EQX
Equinox Gold
0.03
0.93
0.77
Immunocore Holdings PLC Sponsored ADR stock logo
IMCR
Immunocore
0.94
4.62
4.44

Institutional Ownership

CompanyInstitutional Ownership
Birkenstock Holding PLC stock logo
BIRK
Birkenstock
19.93%
Equinox Gold Corp. stock logo
EQX
Equinox Gold
38.85%
Immunocore Holdings PLC Sponsored ADR stock logo
IMCR
Immunocore
84.50%

Insider Ownership

CompanyInsider Ownership
Birkenstock Holding PLC stock logo
BIRK
Birkenstock
N/A
Equinox Gold Corp. stock logo
EQX
Equinox Gold
8.35%
Immunocore Holdings PLC Sponsored ADR stock logo
IMCR
Immunocore
10.10%
CompanyEmployeesShares OutstandingFree FloatOptionable
Birkenstock Holding PLC stock logo
BIRK
Birkenstock
8,400177.89 millionN/AOptionable
Equinox Gold Corp. stock logo
EQX
Equinox Gold
5,2191.17 billion1.07 billionNot Optionable
Immunocore Holdings PLC Sponsored ADR stock logo
IMCR
Immunocore
52451.50 million46.30 millionOptionable

Recent News About These Companies

Baird Reiterates Outperform Rating on Immunocore Holdings (IMCR)
Immunocore FY2026 Earnings Forecast Reduced by HC Wainwright
Immunocore FY2026 Earnings Forecast Cut by HC Wainwright
Immunocore to present at upcoming investor conferences
Immunocore Holdings plc

New MarketBeat Followers Over Time

Media Sentiment Over Time

Birkenstock stock logo

Birkenstock NYSE:BIRK

$34.92 -0.69 (-1.94%)
Closing price 03:59 PM Eastern
Extended Trading
$34.84 -0.08 (-0.21%)
As of 04:34 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

Birkenstock Holding plc manufactures and sells footwear products. It also offers sandals, shoes, closed-toe silhouettes, skincare products, and accessories. The company sells its products through e-commerce sites and a network of owned retail stores, as well as business-to-business channels. It operates in the United States, Brazil, Canada, Mexico, Europe, APMA, and internationally. Birkenstock Holding plc was founded in 1774 and is based in London, the United Kingdom. Birkenstock Holding plc is a subsidiary of BK LC Lux MidCo S.à r.l.

Equinox Gold stock logo

Equinox Gold NYSEAMERICAN:EQX

$9.86 +0.03 (+0.31%)
Closing price 04:10 PM Eastern
Extended Trading
$9.93 +0.07 (+0.70%)
As of 05:05 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

Equinox Gold Corp. engages in the exploration, acquisition, development, and operation of mineral properties in the Americas. It explores gold and silver deposits. It holds interest in properties in California located in the United States; Guerrero State located in Mexico; Maranhão, Bahia, and Mina Gerais state located in Brazil; and Ontario, Canada. The company was formerly known as Trek Mining Inc. and changed its name to Equinox Gold Corp. in December 2017. Equinox Gold Corp. was incorporated in 2007 and is headquartered in Vancouver, Canada.

Immunocore stock logo

Immunocore NASDAQ:IMCR

$27.81 -1.07 (-3.70%)
Closing price 04:00 PM Eastern
Extended Trading
$27.79 -0.02 (-0.07%)
As of 04:10 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

Immunocore Holdings plc, a commercial-stage biotechnology company, engages in the development of immunotherapies for the treatment of cancer, infectious, and autoimmune diseases. The company offers KIMMTRAK for the treatment of patients with unresectable or metastatic uveal melanoma. It also develops other programs for oncology, including tebentafusp that is in Phase 2/3 clinical trial to treat advanced cutaneous melanoma. In addition, the company's product pipeline comprises IMC-F106C, which is in a Phase 3 clinical trial to treat first line advanced cutaneous melanoma; and in a Phase 1/2 clinical trial in multiple tumor types, such as platinum resistant ovarian, non-small cell lung, and endometrial carcinoma. Further, it develops IMC-R117C, which is in phase 1 clinical trial to treat colorectal and gastrointestinal cancers; IMC-M113V, which is in phase 1 clinical trial to treat human immunosuppression virus; IMC-I109V, which is in a Phase I clinical trial in patients with chronic hepatitis B virus; IMC-T119C, which is in preclinical trial for multiple solid tumor cancers; IMC-P115C, which is in preclinical trial to treat multiple solid tumor cancers; and IMC-S118AI to treat type 1 diabetes and is in preclinical trial. Immunocore Holdings plc was founded in 1999 and is headquartered in Abingdon, the United Kingdom.